Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vera M. Witjes"'
Publikováno v:
Gynecologic Oncology Reports, Vol 38, Iss , Pp 100825- (2021)
Externí odkaz:
https://doaj.org/article/244604906aaf4802a9832a1a7d01fdeb
Publikováno v:
Animals, Vol 10, Iss 12, p 2415 (2020)
Irreproducibility is a well-recognized problem in biomedical animal experimentation. Phenotypic variation in animal models is one of the many challenging causes of irreproducibility. How to deal with phenotypic variation in experimental designs is a
Externí odkaz:
https://doaj.org/article/764db051f2184f63a1a537cfadc43ef0
Autor:
Janet R. Vos, Tjalling Bosse, Margreet G. E. M. Ausems, Majke H.D. van Bommel, Marjolijn J. L. Ligtenberg, Marian J.E. Mourits, Nicoline Hoogerbrugge, Vera M. Witjes, Joanne A. de Hullu
Publikováno v:
Gynecologic Oncology, 164, 1, pp. 221-230
Gynecologic Oncology, 164, 221-230
Gynecologic Oncology, 164, 221-230
Contains fulltext : 244552.pdf (Publisher’s version ) (Open Access) BACKGROUND: Histology restricted genetic predisposition testing of ovarian carcinoma patients is a topic of debate as the prevalence of BRCA1/2 pathogenic variants (PVs) in various
Autor:
Vera M. Witjes, Marjolijn J.L. Ligtenberg, Janet R. Vos, Jozé C.C. Braspenning, Margreet G.E.M. Ausems, Marian J.E. Mourits, Joanne A. de Hullu, Eddy M.M. Adang, Nicoline Hoogerbrugge
Publikováno v:
Gynecologic Oncology, 174, pp. 121-128
Gynecologic Oncology, 174, 121-128
Gynecologic Oncology, 174, 121-128
Objective: Genetic testing in epithelial ovarian cancer (OC) is essential to identify a hereditary cause like a germline BRCA1/2 pathogenic variant (PV). An efficient strategy for genetic testing in OC is highly desired. We evaluated costs and effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e688aecb3f810e9269ae2ae895e4067c
Autor:
Vera M. Witjes, Jozé C. C. Braspenning, Nicoline Hoogerbrugge, Yvonne H. C. M. Smolders, Dorien M. A. Hermkens, Marian J. E. Mourits, Marjolijn J. L. Ligtenberg, Margreet G. E. M. Ausems, Joanne A. de Hullu
Publikováno v:
Familial Cancer, 22, 1, pp. 1-11
Familial Cancer. SPRINGER
Familial Cancer, 22, 1-11
Familial Cancer. SPRINGER
Familial Cancer, 22, 1-11
Contains fulltext : 291081.pdf (Publisher’s version ) (Open Access) Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an efficient prescreen for hereditary cancer testing, but may also guide treatment choice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d95233bd0a7e5aaac528b5939b7a00
Autor:
Vera M, Witjes, Jozé C C, Braspenning, Nicoline, Hoogerbrugge, Yvonne H C M, Smolders, Dorien M A, Hermkens, Marian J E, Mourits, Marjolijn J L, Ligtenberg, Margreet G E M, Ausems, Joanne A, de Hullu
Publikováno v:
Familial cancer. 22(1)
Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an efficient prescreen for hereditary cancer testing, but may also guide treatment choices. This innovation, introduced as Tumor-First workflow, offers great o
Autor:
Sebastian Lücker, Carlijn E Bruggeling, Daniel R. Garza, Tanya M. Bisseling, Milou Fransen, Mariëtte C.A. van Kouwen, Joyce P.M. Krekels, Nicoline Hoogerbrugge, Vera M. Witjes, Annemarie Boleij, Iris D. Nagtegaal, Bas E. Dutilh
Publikováno v:
Cancer Research. 80:PR01-PR01
Colonic bacterial biofilms are an emerging manifestation in colorectal cancer (CRC); they exhibit carcinogenic properties and are frequently present on right-sided cancerous lesions. Whether bacterial biofilms propose a risk factor for early carcinog